Jan 14, 2020
Enfortumab vedotin
Enfortumab vedotin
Formula C6642H10284N1742O2063S46 Cas 1346452-25-2 Mol weight 149022.148
AGS-22M6E, enfortumab vedotin-ejfv
Fda approved 2019/12/18, Padcev
Antineoplastic, Nectin-4 antibody, Tubulin polymerization inhibitor, Urothelial cancer
エンホルツマブベドチン (遺伝子組換え);
protein Based Therapies, Monoclonal antibody, mAb,
UNII DLE8519RWM
Immunoglobulin G1, anti-(human nectin-4)…
View On WordPress